Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,17,1.07 [0.77-1.49],0.682430002668384
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,17,0.99 [0.85-1.16],0.93304883462772
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,17,0.89 [0.78-1.02],0.100486750752961
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,17,0.97 [0.81-1.16],0.741331960063463
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,17,0.92 [0.71-1.19],0.523790964143026
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,17,1.00 [0.83-1.22],0.962907235933899
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,17,1.08 [0.86-1.36],0.493996793907651
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,17,1.05 [0.84-1.31],0.644380616387756
CSPG4,Chondroitin sulfate proteoglycan 4,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,17,0.99 [0.73-1.35],0.94840886034337
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,17,1.03 [0.92-1.15],0.606449617807461
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,17,0.97 [0.83-1.13],0.704159680857166
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,17,0.95 [0.87-1.04],0.288360690470687
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,17,0.97 [0.39-2.40],0.945532828485493
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,17,0.97 [0.64-1.48],0.887306113632886
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,17,1.10 [0.83-1.47],0.500109289323256
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,17,1.23 [0.86-1.75],0.255718311170573
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,17,0.68 [0.42-1.10],0.117338960034855
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,17,0.79 [0.56-1.11],0.168342037458713
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Varicose veins,Inverse variance weighted,17,1.06 [0.95-1.19],0.259761288092441
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,17,1.29 [0.91-1.83],0.156631378971294
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,17,1.01 [0.92-1.12],0.797467753166308
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,17,1.15 [0.93-1.42],0.208466393574722
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,17,1.18 [0.90-1.53],0.225884847276076
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,17,0.98 [0.62-1.54],0.919075068039042
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,17,1.11 [0.97-1.27],0.141988523973921
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,17,0.94 [0.78-1.13],0.528296772994213
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,17,0.99 [0.85-1.15],0.907201992912861
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,17,0.93 [0.66-1.32],0.675985074573913
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,17,0.97 [0.86-1.10],0.637705778941964
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,17,1.23 [0.86-1.75],0.260616928977045
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,17,0.98 [0.81-1.19],0.834891462068394
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,17,1.03 [0.97-1.10],0.301970933004525
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,17,0.76 [0.57-1.02],0.0632341618706732
CSPG4,Chondroitin sulfate proteoglycan 4,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,17,1.01 [0.77-1.32],0.955821308618305
